Related Experiment Video
Updated: May 26, 2026
08:18
Focus Formation: A Cell-based Assay to Determine the Oncogenic Potential of a Gene
Published on: December 31, 2014
Recommended protocol for the BALB/c 3T3 cell transformation assay
Kiyoshi Sasaki1, Susanne Bohnenberger, Kumiko Hayashi
1Food and Drug Safety Center, Hadano, Kanagawa, Japan. sasaki.k@fdsc.or.jp
Mutation Research
|January 4, 2012
Summary
This study refines the BALB/c 3T3 cell transformation assay (CTA) protocol based on prevalidation findings. The updated protocol includes optimized criteria for cell culture, dose-range finding, and transformation assessment.
Area of Science:
- Toxicology and Carcinogenesis
- Cell Biology
- Alternative Methods in Toxicology
Background:
- The BALB/c 3T3 cell transformation assay (CTA) is a key method for evaluating chemical carcinogenicity.
- A prevalidation study coordinated by the European Centre for the Validation of Alternative Methods (ECVAM) identified areas for protocol improvement.
Purpose of the Study:
- To present a refined and optimized protocol for the BALB/c 3T3 CTA.
- To incorporate lessons learned from the ECVAM prevalidation study and suggestions from the Validation Management Team (VMT).
Main Methods:
- Detailed description of cell culture maintenance procedures.
- Guidance on conducting the dose-range finding (DRF) experiment.
- Methodology for the transformation assay, including cytotoxicity and morphological transformation evaluation.
Main Results:
- Refined acceptance and assessment criteria compared to the prevalidation study.
- A comprehensive protocol integrating cell culture, DRF, and transformation assessment.
Conclusions:
- The refined BALB/c 3T3 CTA protocol is recommended for future use.
- The protocol is supported by an associated photo catalogue for enhanced morphological evaluation.
